BridgeMD
New treatment option for Breast Cancer
Official title FES BPET-DBT in Newly Diagnosed Breast Cancer
ClinicalTrials.gov ID: NCT05659797
What this study is testing
What is 18F-FES?
18F-FES is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for breast cancer.
Also referred to as 18F-fluoroestradiol.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients with newly diagnosed primary estrogen-receptor (ER) positive breast cancer, with at least one breast lesion that is 1.0 cm in diameter or greater, may be eligible for this study. Patients may participate in this study if they are at least 18 years of age.
- Phase 1: an early, usually small safety study
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Participants will be ≥ 18 years of age.
- Known ER positive (by immunohistochemistry) breast cancer.
- At least one lesion ≥ 1.0 cm that is seen on standard imaging (e.g. mammogram, ultrasound, MRI, CT, FDG-PET/CT). Only one type of imaging is required...
- Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this...
You likely can't join if
- Females who are pregnant or breast feeding will not be eligible for this study; a urine pregnancy test will be performed in women of child-bearing...
- Inability to tolerate imaging procedures in the opinion of an investigator or treating physician.
- Currently taking tamoxifen or raloxifene
- Any current medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician...
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.